Data / Drug companies / Valu Merchandisers Company
Valu Merchandisers Company: 202 products in the FDA NDC directory, labeler code 63941
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Valu Merchandisers Company (labeler code 63941) lists 202 products in the FDA National Drug Code Directory, covering 109 finished drugs by generic name. By type: 202 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on January 1, 2025.
The request: Watch Valu Merchandisers Company (FDA labeler code 63941): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 63941
- Products in commercial distribution
- 202
- Packages
- 268
- Finished drugs by generic name
- 109
- Prescription products
- 0
- Over the counter products
- 202
- Flagged as original packager
- 201 of 201 products that carry the flag
- Started marketing in the last 12 months
- 0
- Products with a marketing end date set
- 77
- Earliest marketing start
- November 17, 1992
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 165 | 81.7% |
| Generic drugs (ANDA) | 34 | 16.8% |
| New drug applications (NDA) | 2 | 1% |
| Other unapproved drugs | 1 | 0.5% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 202 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Liquid | 31 | 15.3% |
| Tablet, coated | 24 | 11.9% |
| Tablet | 21 | 10.4% |
| Capsule, liquid filled | 13 | 6.4% |
| Tablet, chewable | 12 | 5.9% |
| Spray | 11 | 5.4% |
| Tablet, film coated | 10 | 5% |
| Suspension | 10 | 5% |
| Gel | 6 | 3% |
| Solution | 6 | 3% |
| Tablet, delayed release | 6 | 3% |
| Shampoo | 5 | 2.5% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| DM Max | 63941-518 | Solution | Over the counter monograph drugs | January 1, 2025 |
| Severe Congestion and Cough Max | 63941-517 | Solution | Over the counter monograph drugs | January 1, 2025 |
| Childrens Allergy Relief | 63941-505 | Solution | Over the counter monograph drugs | January 1, 2025 |
| Childrens Ibuprofen Oral Suspension, Dye Free | 63941-128 | Suspension | Generic drugs (ANDA) | January 1, 2025 |
| Childrens Ibuprofen Oral Suspension, Bubble Gum | 63941-127 | Suspension | Generic drugs (ANDA) | January 1, 2025 |
| Best Choice Extra Strength | 63941-115 | Tablet, chewable | Over the counter monograph drugs | October 4, 2024 |
| Best Choice Ultra Strength | 63941-031 | Tablet, chewable | Over the counter monograph drugs | October 4, 2024 |
| Best Choice Targeted Warming Capsaicin Heat Patch | 63941-691 | Patch | Over the counter monograph drugs | August 1, 2024 |
| Tussin CF | 63941-823 | Liquid | Over the counter monograph drugs | June 1, 2024 |
| Nighttime Sleep-Aid | 63941-604 | Capsule, liquid filled | Over the counter monograph drugs | May 1, 2024 |
| Naproxen Sodium | 63941-445 | Tablet, coated | Generic drugs (ANDA) | May 1, 2024 |
| Naproxen Sodium | 63941-444 | Tablet, coated | Generic drugs (ANDA) | May 1, 2024 |
| Adult low dose aspirin | 63941-246 | Tablet, delayed release | Over the counter monograph drugs | May 1, 2024 |
| Cough Relief | 63941-455 | Liquid | Over the counter monograph drugs | March 15, 2024 |
| Best Choice Effervescent Pain Reliever 36 | 63941-241 | Tablet, effervescent | Over the counter monograph drugs | February 13, 2024 |
| Best Choice Eye Drops Original | 63941-139 | Solution/ drops | Over the counter monograph drugs | January 1, 2024 |
| Gas Relief | 63941-152 | Capsule, liquid filled | Over the counter monograph drugs | December 31, 2023 |
| Daily Moisturizing | 63941-620 | Lotion | Over the counter monograph drugs | December 18, 2023 |
| Sport Sunscreen SPF 30 | 63941-149 | Spray | Over the counter monograph drugs | November 7, 2023 |
| Acetaminophen | 63941-404 | Tablet, coated | Over the counter monograph drugs | October 29, 2023 |
| Ibuprofen | 63941-209 | Tablet, coated | Generic drugs (ANDA) | October 29, 2023 |
| Aspirin | 63941-118 | Tablet, coated | Over the counter monograph drugs | October 17, 2023 |
| Nighttime Sleep-Aid | 63941-683 | Capsule, liquid filled | Over the counter monograph drugs | October 12, 2023 |
| Anti-diarrheal | 63941-684 | Capsule, liquid filled | New drug applications (NDA) | October 10, 2023 |
| Ibuprofen | 63941-680 | Capsule, liquid filled | Generic drugs (ANDA) | October 5, 2023 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.